Rank | Gene Set | Z-score |
---|---|---|
1 | platelet dense granule organization (GO:0060155) | 8.27606803 |
2 | thrombin receptor signaling pathway (GO:0070493) | 7.61116395 |
3 | positive regulation of p38MAPK cascade (GO:1900745) | 6.57720446 |
4 | Golgi transport vesicle coating (GO:0048200) | 5.63503987 |
5 | COPI coating of Golgi vesicle (GO:0048205) | 5.63503987 |
6 | activation of MAPKKK activity (GO:0000185) | 5.41222144 |
7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.99211287 |
8 | protein retention in ER lumen (GO:0006621) | 4.68001673 |
9 | basement membrane organization (GO:0071711) | 4.60285545 |
10 | proline biosynthetic process (GO:0006561) | 4.59279512 |
11 | regulation of p38MAPK cascade (GO:1900744) | 4.39927460 |
12 | negative regulation of lipid storage (GO:0010888) | 4.37062045 |
13 | wound healing, spreading of epidermal cells (GO:0035313) | 4.22101238 |
14 | low-density lipoprotein particle clearance (GO:0034383) | 4.12276015 |
15 | positive regulation of lipid storage (GO:0010884) | 4.05646125 |
16 | secretory granule organization (GO:0033363) | 3.94082109 |
17 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.91644494 |
18 | glucose 6-phosphate metabolic process (GO:0051156) | 3.91080415 |
19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.90210126 |
20 | skin morphogenesis (GO:0043589) | 3.86800381 |
21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.74644659 |
22 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.73180101 |
23 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.72230862 |
24 | response to muramyl dipeptide (GO:0032495) | 3.70497883 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67970773 |
26 | modulation by symbiont of host defense response (GO:0052031) | 3.67970773 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67970773 |
28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67970773 |
29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67970773 |
30 | modulation by symbiont of host immune response (GO:0052553) | 3.67970773 |
31 | neutrophil activation involved in immune response (GO:0002283) | 3.64815400 |
32 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.62265420 |
33 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.60670050 |
34 | positive regulation of nuclease activity (GO:0032075) | 3.58620630 |
35 | proline metabolic process (GO:0006560) | 3.56207301 |
36 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.52866849 |
37 | RNA destabilization (GO:0050779) | 3.52366633 |
38 | regulation of lipid storage (GO:0010883) | 3.51069699 |
39 | apoptotic cell clearance (GO:0043277) | 3.50657718 |
40 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.50226463 |
41 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.47536136 |
42 | mesodermal cell differentiation (GO:0048333) | 3.42672358 |
43 | protein localization to endosome (GO:0036010) | 3.38164517 |
44 | regulation of metalloenzyme activity (GO:0048552) | 3.36661260 |
45 | lung vasculature development (GO:0060426) | 3.35064002 |
46 | peptidyl-proline hydroxylation (GO:0019511) | 3.32374365 |
47 | endothelial cell chemotaxis (GO:0035767) | 3.32229489 |
48 | cell adhesion mediated by integrin (GO:0033627) | 3.30133435 |
49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28586936 |
50 | cellular response to unfolded protein (GO:0034620) | 3.28396828 |
51 | L-serine transport (GO:0015825) | 3.28249466 |
52 | ER-nucleus signaling pathway (GO:0006984) | 3.27959907 |
53 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.26566438 |
54 | intestinal cholesterol absorption (GO:0030299) | 3.22162816 |
55 | flavonoid metabolic process (GO:0009812) | 3.22081682 |
56 | NIK/NF-kappaB signaling (GO:0038061) | 3.21399884 |
57 | plasma lipoprotein particle assembly (GO:0034377) | 3.14806467 |
58 | protein hydroxylation (GO:0018126) | 3.14737370 |
59 | regulation of nuclease activity (GO:0032069) | 3.14322759 |
60 | regulation of response to osmotic stress (GO:0047484) | 3.14011487 |
61 | response to peptidoglycan (GO:0032494) | 3.11794134 |
62 | plasma lipoprotein particle clearance (GO:0034381) | 3.11762138 |
63 | ER overload response (GO:0006983) | 3.08845106 |
64 | regulation of plasminogen activation (GO:0010755) | 3.08399568 |
65 | positive regulation of heat generation (GO:0031652) | 3.08381761 |
66 | hyaluronan catabolic process (GO:0030214) | 3.08152107 |
67 | negative regulation of fibrinolysis (GO:0051918) | 3.08015377 |
68 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.07827522 |
69 | regulation of translational fidelity (GO:0006450) | 3.06443871 |
70 | regulation of cholesterol storage (GO:0010885) | 3.04293483 |
71 | cellular response to topologically incorrect protein (GO:0035967) | 3.04020953 |
72 | macrophage activation involved in immune response (GO:0002281) | 3.03325374 |
73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02911323 |
74 | desmosome organization (GO:0002934) | 3.02167250 |
75 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.01338880 |
76 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.99980592 |
77 | GDP-mannose metabolic process (GO:0019673) | 2.99504599 |
78 | protein-lipid complex assembly (GO:0065005) | 2.99230995 |
79 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99107646 |
80 | decidualization (GO:0046697) | 2.98853292 |
81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.98437081 |
82 | macroautophagy (GO:0016236) | 2.96262736 |
83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.95263400 |
84 | regulation of early endosome to late endosome transport (GO:2000641) | 2.93654463 |
85 | myeloid cell homeostasis (GO:0002262) | 2.92001955 |
86 | protein maturation by protein folding (GO:0022417) | 2.90954555 |
87 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.89672307 |
88 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89247479 |
89 | serine transport (GO:0032329) | 2.88344681 |
90 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.88174656 |
91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.87970119 |
92 | L-phenylalanine metabolic process (GO:0006558) | 2.87970119 |
93 | response to endoplasmic reticulum stress (GO:0034976) | 2.86154334 |
94 | aldehyde catabolic process (GO:0046185) | 2.81822872 |
95 | carnitine metabolic process (GO:0009437) | 2.81525351 |
96 | protein carboxylation (GO:0018214) | 2.80369064 |
97 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.80369064 |
98 | positive regulation of extracellular matrix organization (GO:1903055) | 2.79609125 |
99 | response to laminar fluid shear stress (GO:0034616) | 2.78530425 |
100 | oligosaccharide catabolic process (GO:0009313) | 2.77306029 |
101 | positive regulation of cholesterol efflux (GO:0010875) | 2.76649284 |
102 | positive regulation of hormone metabolic process (GO:0032352) | 2.76552274 |
103 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.76342194 |
104 | wound healing, spreading of cells (GO:0044319) | 2.74418948 |
105 | lung epithelium development (GO:0060428) | 2.74367689 |
106 | amino-acid betaine metabolic process (GO:0006577) | 2.73936770 |
107 | response to arsenic-containing substance (GO:0046685) | 2.73679738 |
108 | endothelial cell morphogenesis (GO:0001886) | 2.73313666 |
109 | positive regulation of blood coagulation (GO:0030194) | 2.73010862 |
110 | positive regulation of hemostasis (GO:1900048) | 2.73010862 |
111 | positive regulation of coagulation (GO:0050820) | 2.71679121 |
112 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.70202665 |
113 | regulation of fever generation (GO:0031620) | 2.69433303 |
114 | positive regulation of sterol transport (GO:0032373) | 2.68551817 |
115 | positive regulation of cholesterol transport (GO:0032376) | 2.68551817 |
116 | cellular zinc ion homeostasis (GO:0006882) | 2.67299139 |
117 | embryo implantation (GO:0007566) | 2.65594863 |
118 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65483040 |
119 | urea metabolic process (GO:0019627) | 2.65259945 |
120 | urea cycle (GO:0000050) | 2.65259945 |
121 | negative regulation of fatty acid transport (GO:2000192) | 2.65131576 |
122 | endocardial cushion development (GO:0003197) | 2.64960022 |
123 | response to gravity (GO:0009629) | 2.64248531 |
124 | cellular copper ion homeostasis (GO:0006878) | 2.63429767 |
125 | negative regulation of adherens junction organization (GO:1903392) | 2.63223905 |
126 | negative regulation of focal adhesion assembly (GO:0051895) | 2.63223905 |
127 | negative regulation of cell junction assembly (GO:1901889) | 2.63223905 |
128 | cell-substrate junction assembly (GO:0007044) | 2.62601881 |
129 | mammary gland epithelial cell proliferation (GO:0033598) | 2.62545980 |
130 | positive regulation of lipid catabolic process (GO:0050996) | 2.62069895 |
131 | establishment of apical/basal cell polarity (GO:0035089) | 2.60367014 |
132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60122808 |
133 | endodermal cell differentiation (GO:0035987) | 2.59894771 |
134 | positive regulation of osteoblast proliferation (GO:0033690) | 2.59242105 |
135 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.58750924 |
136 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.58750924 |
137 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 2.58484730 |
138 | adherens junction assembly (GO:0034333) | 2.57445563 |
139 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.56866800 |
140 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56464407 |
141 | melanin biosynthetic process (GO:0042438) | 2.56313338 |
142 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.56278281 |
143 | acute-phase response (GO:0006953) | 2.55437907 |
144 | focal adhesion assembly (GO:0048041) | 2.55297064 |
145 | cell-substrate adherens junction assembly (GO:0007045) | 2.55297064 |
146 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54733411 |
147 | activation of Rac GTPase activity (GO:0032863) | 2.54616481 |
148 | respiratory burst (GO:0045730) | 2.53982885 |
149 | hyaluronan metabolic process (GO:0030212) | 2.53278892 |
150 | regulation of podosome assembly (GO:0071801) | 2.53201673 |
151 | COPII vesicle coating (GO:0048208) | 2.53097183 |
152 | adhesion of symbiont to host (GO:0044406) | 2.52211246 |
153 | hemoglobin metabolic process (GO:0020027) | 2.52123825 |
154 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.50655779 |
155 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.50483099 |
156 | endoderm formation (GO:0001706) | 2.50425867 |
157 | regulation of apoptotic cell clearance (GO:2000425) | 2.49735826 |
158 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 2.49171507 |
159 | semaphorin-plexin signaling pathway (GO:0071526) | 2.48654803 |
160 | positive regulation of mRNA catabolic process (GO:0061014) | 2.48134219 |
161 | regulation of mRNA catabolic process (GO:0061013) | 2.47956036 |
162 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.47353929 |
163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46874722 |
164 | mitochondrial DNA metabolic process (GO:0032042) | 2.46068048 |
165 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.45431804 |
166 | T-helper 1 type immune response (GO:0042088) | 2.45302380 |
167 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.44550131 |
168 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.44459796 |
169 | surfactant homeostasis (GO:0043129) | 2.44270082 |
170 | regulation of cholesterol esterification (GO:0010872) | 2.43333932 |
171 | adhesion of symbiont to host cell (GO:0044650) | 2.43083065 |
172 | virion attachment to host cell (GO:0019062) | 2.43083065 |
173 | nitrogen cycle metabolic process (GO:0071941) | 2.42872715 |
174 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.42311652 |
175 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41979953 |
176 | granulocyte activation (GO:0036230) | 2.41915356 |
177 | response to unfolded protein (GO:0006986) | 2.41837700 |
178 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.41696801 |
179 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.41696801 |
180 | positive regulation of macrophage differentiation (GO:0045651) | 2.41084698 |
181 | response to progesterone (GO:0032570) | 2.40725123 |
182 | regulation of mononuclear cell migration (GO:0071675) | 2.40671420 |
183 | chondrocyte proliferation (GO:0035988) | 2.40338073 |
184 | regulation of fibrinolysis (GO:0051917) | 2.40075266 |
185 | vesicle coating (GO:0006901) | 2.40027232 |
186 | regulation of cholesterol homeostasis (GO:2000188) | 2.39811093 |
187 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.39099715 |
188 | positive regulation of astrocyte differentiation (GO:0048711) | 2.38077407 |
189 | cysteine metabolic process (GO:0006534) | 2.37198280 |
190 | glycolipid catabolic process (GO:0019377) | 2.37176489 |
191 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.36496799 |
192 | phagosome maturation (GO:0090382) | 2.36071867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 6.08770622 |
2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.81154546 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.54251023 |
4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.32916841 |
5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20876943 |
6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.16617308 |
7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.08396105 |
8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.08131559 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.84877631 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83191140 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80521031 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78785024 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.72377697 |
14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69681408 |
15 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.65772755 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59551160 |
17 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55547245 |
18 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54022484 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.44302802 |
20 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.39577946 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.32056126 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31029250 |
23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23114085 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22921287 |
25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12582690 |
26 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.09481228 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05556205 |
28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02443585 |
29 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.98821628 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96443708 |
31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92582928 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83232646 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75879533 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72325450 |
35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71832469 |
36 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.69753446 |
37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68195433 |
38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.64689335 |
39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64296068 |
40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63713823 |
41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63609727 |
42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62993130 |
43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59916829 |
44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59338275 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58391392 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58136726 |
47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57185555 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52911892 |
49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52751653 |
50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52143048 |
51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51675734 |
52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50527609 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49395640 |
54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48264164 |
55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46280507 |
56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44158671 |
57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42073585 |
58 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40973247 |
59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39414679 |
60 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38909441 |
61 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38857629 |
62 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.37844246 |
63 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.36894986 |
64 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35813468 |
65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34990605 |
66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34969583 |
67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.34881688 |
68 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.34426715 |
69 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32295546 |
70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31221246 |
71 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.31083337 |
72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28684920 |
73 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28376480 |
74 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28049089 |
75 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27183673 |
76 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.27013214 |
77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26608714 |
78 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25928537 |
79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25852758 |
80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.25824046 |
81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25519602 |
82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25519602 |
83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24578623 |
84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24238122 |
85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24142852 |
86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23867038 |
87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22066950 |
88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22038076 |
89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20603053 |
90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20489029 |
91 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19130304 |
92 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18704319 |
93 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.18622710 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17497127 |
95 | MAF_26560356_Chip-Seq_TH1_Human | 1.16859499 |
96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16596649 |
97 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15462486 |
98 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14586589 |
99 | P68_20966046_ChIP-Seq_HELA_Human | 1.12017256 |
100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11766829 |
101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11749285 |
102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11029046 |
103 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10888396 |
104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10357436 |
105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10199415 |
106 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08611861 |
107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08384598 |
108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08112542 |
109 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07617754 |
110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07313036 |
111 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06630356 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06509301 |
113 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06446627 |
114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05865148 |
115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05382239 |
116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04490905 |
117 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04065589 |
118 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04065589 |
119 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04065589 |
120 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03934439 |
121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03793550 |
122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03793550 |
123 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03380798 |
124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03333800 |
125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03277860 |
126 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02717637 |
127 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02668842 |
128 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02649326 |
129 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01704591 |
130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01634871 |
131 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01277874 |
132 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.00854926 |
133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00765589 |
134 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00548650 |
135 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00447352 |
136 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00137370 |
137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98263837 |
138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97271285 |
139 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94652630 |
140 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92727851 |
141 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91616495 |
142 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.90676273 |
143 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90449985 |
144 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89920245 |
145 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89089044 |
146 | * MYC_22102868_ChIP-Seq_BL_Human | 0.88663406 |
147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88193076 |
148 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87194497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 4.47219965 |
2 | MP0005451_abnormal_body_composition | 4.05203733 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.64907080 |
4 | MP0004272_abnormal_basement_membrane | 3.60456088 |
5 | MP0003436_decreased_susceptibility_to | 3.56571991 |
6 | MP0009840_abnormal_foam_cell | 3.02945676 |
7 | MP0004510_myositis | 2.96810566 |
8 | MP0005257_abnormal_intraocular_pressure | 2.94267613 |
9 | MP0003303_peritoneal_inflammation | 2.92809058 |
10 | MP0005408_hypopigmentation | 2.77936902 |
11 | MP0001853_heart_inflammation | 2.67395435 |
12 | MP0005171_absent_coat_pigmentation | 2.59488381 |
13 | MP0004947_skin_inflammation | 2.49883586 |
14 | MP0004264_abnormal_extraembryonic_tissu | 2.49150133 |
15 | MP0005365_abnormal_bile_salt | 2.46881194 |
16 | MP0002419_abnormal_innate_immunity | 2.46856684 |
17 | MP0010352_gastrointestinal_tract_polyps | 2.42583377 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.36316016 |
19 | MP0004858_abnormal_nervous_system | 2.34065451 |
20 | MP0002089_abnormal_postnatal_growth/wei | 2.30479266 |
21 | MP0005360_urolithiasis | 2.29130977 |
22 | MP0008260_abnormal_autophagy | 2.24722060 |
23 | MP0005000_abnormal_immune_tolerance | 2.21824498 |
24 | MP0002877_abnormal_melanocyte_morpholog | 2.21113723 |
25 | MP0005058_abnormal_lysosome_morphology | 2.13311290 |
26 | MP0001835_abnormal_antigen_presentation | 2.12683140 |
27 | MP0003448_altered_tumor_morphology | 2.05002828 |
28 | MP0009785_altered_susceptibility_to | 2.01481836 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.98590585 |
30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96123365 |
31 | MP0003453_abnormal_keratinocyte_physiol | 1.91924268 |
32 | MP0005464_abnormal_platelet_physiology | 1.87800152 |
33 | MP0003724_increased_susceptibility_to | 1.82072407 |
34 | MP0000569_abnormal_digit_pigmentation | 1.81935614 |
35 | MP0002452_abnormal_antigen_presenting | 1.81658301 |
36 | MP0003075_altered_response_to | 1.76861140 |
37 | MP0005025_abnormal_response_to | 1.76479297 |
38 | MP0003123_paternal_imprinting | 1.76363986 |
39 | MP0006082_CNS_inflammation | 1.75579431 |
40 | MP0005409_darkened_coat_color | 1.73740960 |
41 | MP0005076_abnormal_cell_differentiation | 1.71556011 |
42 | MP0001533_abnormal_skeleton_physiology | 1.71304809 |
43 | MP0005085_abnormal_gallbladder_physiolo | 1.68053902 |
44 | MP0002148_abnormal_hypersensitivity_rea | 1.67805260 |
45 | MP0010234_abnormal_vibrissa_follicle | 1.63932181 |
46 | MP0009764_decreased_sensitivity_to | 1.62430085 |
47 | MP0004233_abnormal_muscle_weight | 1.62021897 |
48 | MP0003566_abnormal_cell_adhesion | 1.61469863 |
49 | MP0002933_joint_inflammation | 1.55624050 |
50 | MP0002138_abnormal_hepatobiliary_system | 1.55574793 |
51 | MP0003172_abnormal_lysosome_physiology | 1.52592732 |
52 | MP0002723_abnormal_immune_serum | 1.51809376 |
53 | MP0009278_abnormal_bone_marrow | 1.51508154 |
54 | MP0002060_abnormal_skin_morphology | 1.50726695 |
55 | MP0010329_abnormal_lipoprotein_level | 1.48685787 |
56 | MP0001800_abnormal_humoral_immune | 1.46759652 |
57 | MP0002254_reproductive_system_inflammat | 1.45927061 |
58 | MP0001845_abnormal_inflammatory_respons | 1.45563359 |
59 | MP0000371_diluted_coat_color | 1.44030886 |
60 | MP0001915_intracranial_hemorrhage | 1.42558477 |
61 | MP0003941_abnormal_skin_development | 1.40464824 |
62 | MP0003183_abnormal_peptide_metabolism | 1.36504378 |
63 | MP0003195_calcinosis | 1.36107233 |
64 | MP0008469_abnormal_protein_level | 1.35660811 |
65 | MP0003186_abnormal_redox_activity | 1.34938061 |
66 | MP0001851_eye_inflammation | 1.34252199 |
67 | MP0000678_abnormal_parathyroid_gland | 1.34216807 |
68 | MP0005501_abnormal_skin_physiology | 1.34170533 |
69 | MP0001849_ear_inflammation | 1.33440879 |
70 | MP0003806_abnormal_nucleotide_metabolis | 1.32300761 |
71 | MP0001819_abnormal_immune_cell | 1.32073825 |
72 | MP0002420_abnormal_adaptive_immunity | 1.31383799 |
73 | MP0005387_immune_system_phenotype | 1.30169171 |
74 | MP0001790_abnormal_immune_system | 1.30169171 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 1.29968610 |
76 | MP0000858_altered_metastatic_potential | 1.29854137 |
77 | MP0003252_abnormal_bile_duct | 1.29776930 |
78 | MP0005164_abnormal_response_to | 1.29151291 |
79 | MP0002405_respiratory_system_inflammati | 1.26373706 |
80 | MP0000566_synostosis | 1.26370338 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 1.25422174 |
82 | MP0005023_abnormal_wound_healing | 1.25413053 |
83 | MP0000604_amyloidosis | 1.24224811 |
84 | MP0000609_abnormal_liver_physiology | 1.22515194 |
85 | MP0000343_altered_response_to | 1.22143554 |
86 | MP0005670_abnormal_white_adipose | 1.21370752 |
87 | MP0005166_decreased_susceptibility_to | 1.18629934 |
88 | MP0002998_abnormal_bone_remodeling | 1.17532084 |
89 | MP0010155_abnormal_intestine_physiology | 1.16115605 |
90 | MP0002166_altered_tumor_susceptibility | 1.15812019 |
91 | MP0003879_abnormal_hair_cell | 1.15758367 |
92 | MP0002006_tumorigenesis | 1.11979978 |
93 | MP0001545_abnormal_hematopoietic_system | 1.11216668 |
94 | MP0005397_hematopoietic_system_phenotyp | 1.11216668 |
95 | MP0000249_abnormal_blood_vessel | 1.09390690 |
96 | MP0005332_abnormal_amino_acid | 1.07743997 |
97 | MP0001666_abnormal_nutrient_absorption | 1.07667160 |
98 | MP0004883_abnormal_blood_vessel | 1.07238540 |
99 | MP0000627_abnormal_mammary_gland | 1.06775252 |
100 | MP0004381_abnormal_hair_follicle | 1.06753014 |
101 | MP0001501_abnormal_sleep_pattern | 1.05834325 |
102 | MP0000534_abnormal_ureter_morphology | 1.05066468 |
103 | MP0000003_abnormal_adipose_tissue | 1.04904212 |
104 | MP0000689_abnormal_spleen_morphology | 1.04209940 |
105 | MP0000685_abnormal_immune_system | 1.03628407 |
106 | MP0000372_irregular_coat_pigmentation | 1.03276149 |
107 | MP0001958_emphysema | 1.02660831 |
108 | MP0002075_abnormal_coat/hair_pigmentati | 1.02203548 |
109 | MP0003300_gastrointestinal_ulcer | 1.02071856 |
110 | MP0003828_pulmonary_edema | 1.01156961 |
111 | MP0003656_abnormal_erythrocyte_physiolo | 1.00068759 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.99817777 |
113 | MP0003136_yellow_coat_color | 0.99719216 |
114 | MP0005083_abnormal_biliary_tract | 0.98468056 |
115 | MP0001186_pigmentation_phenotype | 0.98394500 |
116 | MP0009384_cardiac_valve_regurgitation | 0.96315250 |
117 | MP0002796_impaired_skin_barrier | 0.94524635 |
118 | MP0002136_abnormal_kidney_physiology | 0.92981447 |
119 | MP0009763_increased_sensitivity_to | 0.92719806 |
120 | MP0003315_abnormal_perineum_morphology | 0.92622353 |
121 | MP0002928_abnormal_bile_duct | 0.92436432 |
122 | MP0002118_abnormal_lipid_homeostasis | 0.92403174 |
123 | MP0005390_skeleton_phenotype | 0.90976176 |
124 | MP0005174_abnormal_tail_pigmentation | 0.89887703 |
125 | MP0001881_abnormal_mammary_gland | 0.89831028 |
126 | MP0001661_extended_life_span | 0.89679472 |
127 | MP0002722_abnormal_immune_system | 0.89378066 |
128 | MP0000747_muscle_weakness | 0.86282892 |
129 | MP0000015_abnormal_ear_pigmentation | 0.85432830 |
130 | MP0000716_abnormal_immune_system | 0.85374128 |
131 | MP0003942_abnormal_urinary_system | 0.84624221 |
132 | MP0002098_abnormal_vibrissa_morphology | 0.84030077 |
133 | MP0009643_abnormal_urine_homeostasis | 0.83247122 |
134 | MP0002896_abnormal_bone_mineralization | 0.83176166 |
135 | MP0000537_abnormal_urethra_morphology | 0.82624989 |
136 | MP0000598_abnormal_liver_morphology | 0.82604963 |
137 | MP0002295_abnormal_pulmonary_circulatio | 0.82242083 |
138 | MP0003091_abnormal_cell_migration | 0.82233405 |
139 | MP0009333_abnormal_splenocyte_physiolog | 0.81662102 |
140 | MP0010030_abnormal_orbit_morphology | 0.81149842 |
141 | MP0005621_abnormal_cell_physiology | 0.77241038 |
142 | MP0002086_abnormal_extraembryonic_tissu | 0.77115458 |
143 | MP0005197_abnormal_uvea_morphology | 0.76853860 |
144 | MP0009931_abnormal_skin_appearance | 0.74925473 |
145 | MP0004782_abnormal_surfactant_physiolog | 0.74783554 |
146 | MP0005084_abnormal_gallbladder_morpholo | 0.74390085 |
147 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73758491 |
148 | MP0003279_aneurysm | 0.73052302 |
149 | MP0002398_abnormal_bone_marrow | 0.72912169 |
150 | MP0010771_integument_phenotype | 0.72654930 |
151 | MP0005508_abnormal_skeleton_morphology | 0.71876619 |
152 | MP0003634_abnormal_glial_cell | 0.71341053 |
153 | MP0001216_abnormal_epidermal_layer | 0.71127101 |
154 | MP0005165_increased_susceptibility_to | 0.70471062 |
155 | MP0005384_cellular_phenotype | 0.68680994 |
156 | MP0006138_congestive_heart_failure | 0.68346968 |
157 | MP0000358_abnormal_cell_content/ | 0.67377794 |
158 | MP0000767_abnormal_smooth_muscle | 0.67085571 |
159 | MP0008775_abnormal_heart_ventricle | 0.65602909 |
160 | MP0004019_abnormal_vitamin_homeostasis | 0.65084478 |
161 | MP0003329_amyloid_beta_deposits | 0.65020796 |
162 | MP0003122_maternal_imprinting | 0.64557703 |
163 | MP0005636_abnormal_mineral_homeostasis | 0.63583821 |
164 | MP0000733_abnormal_muscle_development | 0.62941069 |
165 | MP0003385_abnormal_body_wall | 0.62011700 |
166 | MP0001614_abnormal_blood_vessel | 0.61655541 |
167 | MP0005375_adipose_tissue_phenotype | 0.61652302 |
168 | MP0004808_abnormal_hematopoietic_stem | 0.60704015 |
169 | MP0003115_abnormal_respiratory_system | 0.60617739 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.85535457 |
2 | Recurrent abscess formation (HP:0002722) | 4.31213862 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26545303 |
4 | Eczematoid dermatitis (HP:0000976) | 4.26185067 |
5 | Protrusio acetabuli (HP:0003179) | 4.20505747 |
6 | Axonal loss (HP:0003447) | 4.11976554 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.88852929 |
8 | Xanthomatosis (HP:0000991) | 3.78489681 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77350510 |
10 | Premature rupture of membranes (HP:0001788) | 3.77023162 |
11 | Abnormality of proline metabolism (HP:0010907) | 3.76177771 |
12 | Hydroxyprolinuria (HP:0003080) | 3.76177771 |
13 | Increased cerebral lipofuscin (HP:0011813) | 3.74652779 |
14 | Abnormality of macrophages (HP:0004311) | 3.74540751 |
15 | Vacuolated lymphocytes (HP:0001922) | 3.70881180 |
16 | Cerebral aneurysm (HP:0004944) | 3.46676992 |
17 | Stomatitis (HP:0010280) | 3.41482933 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 3.39474642 |
19 | Reticulocytosis (HP:0001923) | 3.38290232 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37819287 |
21 | Amyloidosis (HP:0011034) | 3.37246198 |
22 | Upper limb amyotrophy (HP:0009129) | 3.35390516 |
23 | Distal upper limb amyotrophy (HP:0007149) | 3.35390516 |
24 | Interstitial pulmonary disease (HP:0006530) | 3.26686991 |
25 | Intrahepatic cholestasis (HP:0001406) | 3.26263673 |
26 | Hand muscle atrophy (HP:0009130) | 3.22680953 |
27 | Deep venous thrombosis (HP:0002625) | 3.21931198 |
28 | Achilles tendon contracture (HP:0001771) | 3.18371778 |
29 | Joint hemorrhage (HP:0005261) | 3.05643740 |
30 | J-shaped sella turcica (HP:0002680) | 3.03041251 |
31 | Hyperlipoproteinemia (HP:0010980) | 2.99501338 |
32 | Increased serum ferritin (HP:0003281) | 2.97387309 |
33 | Hypercholesterolemia (HP:0003124) | 2.96456977 |
34 | Abnormal gallbladder physiology (HP:0012438) | 2.95320399 |
35 | Cholecystitis (HP:0001082) | 2.95320399 |
36 | Tetraparesis (HP:0002273) | 2.93284833 |
37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.93030985 |
38 | Systemic lupus erythematosus (HP:0002725) | 2.92011833 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.90986681 |
40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.89566687 |
41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.89566687 |
42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.89566687 |
43 | Bone cyst (HP:0012062) | 2.88171284 |
44 | Gingival bleeding (HP:0000225) | 2.83945737 |
45 | Myocardial infarction (HP:0001658) | 2.83153384 |
46 | Paraparesis (HP:0002385) | 2.79509023 |
47 | Flat acetabular roof (HP:0003180) | 2.78095650 |
48 | Abnormality of iron homeostasis (HP:0011031) | 2.75985082 |
49 | Hyperacusis (HP:0010780) | 2.75927807 |
50 | Gingivitis (HP:0000230) | 2.75819192 |
51 | Menorrhagia (HP:0000132) | 2.64423466 |
52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.60241617 |
53 | Dysostosis multiplex (HP:0000943) | 2.58948475 |
54 | Elbow flexion contracture (HP:0002987) | 2.58589786 |
55 | Recurrent skin infections (HP:0001581) | 2.56488242 |
56 | Cervical subluxation (HP:0003308) | 2.55531023 |
57 | Pustule (HP:0200039) | 2.52516215 |
58 | Small epiphyses (HP:0010585) | 2.50773190 |
59 | Cardiovascular calcification (HP:0011915) | 2.50118688 |
60 | Growth hormone excess (HP:0000845) | 2.47916683 |
61 | Diaphragmatic weakness (HP:0009113) | 2.45137810 |
62 | Prolonged partial thromboplastin time (HP:0003645) | 2.43572825 |
63 | Complement deficiency (HP:0004431) | 2.42926753 |
64 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.38556736 |
65 | Hyperglycinuria (HP:0003108) | 2.37109791 |
66 | Urticaria (HP:0001025) | 2.36108463 |
67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34738091 |
68 | Broad face (HP:0000283) | 2.32348233 |
69 | Upper limb muscle weakness (HP:0003484) | 2.32276870 |
70 | Periodontitis (HP:0000704) | 2.31853171 |
71 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.31657073 |
72 | Myositis (HP:0100614) | 2.29802259 |
73 | Pancreatitis (HP:0001733) | 2.29421269 |
74 | Albinism (HP:0001022) | 2.26906053 |
75 | Mucopolysacchariduria (HP:0008155) | 2.26569466 |
76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26569466 |
77 | Insomnia (HP:0100785) | 2.26433401 |
78 | Cholelithiasis (HP:0001081) | 2.21920501 |
79 | Skin nodule (HP:0200036) | 2.21232717 |
80 | Premature skin wrinkling (HP:0100678) | 2.20563358 |
81 | Abnormality of carpal bone ossification (HP:0006257) | 2.19169895 |
82 | Glomerulonephritis (HP:0000099) | 2.18380224 |
83 | Hemorrhage of the eye (HP:0011885) | 2.16125585 |
84 | Abnormality of complement system (HP:0005339) | 2.15524825 |
85 | Abnormality of the acetabulum (HP:0003170) | 2.15028265 |
86 | Distal lower limb muscle weakness (HP:0009053) | 2.13328981 |
87 | Esophageal varix (HP:0002040) | 2.13221776 |
88 | Spastic paraparesis (HP:0002313) | 2.12514613 |
89 | Hematochezia (HP:0002573) | 2.12009169 |
90 | Autoimmune thrombocytopenia (HP:0001973) | 2.11799486 |
91 | Nephritis (HP:0000123) | 2.11618456 |
92 | Epistaxis (HP:0000421) | 2.11243686 |
93 | Vertebral compression fractures (HP:0002953) | 2.10708328 |
94 | Polycythemia (HP:0001901) | 2.10597450 |
95 | Disinhibition (HP:0000734) | 2.08691879 |
96 | Ankle contracture (HP:0006466) | 2.07422564 |
97 | Trismus (HP:0000211) | 2.06868333 |
98 | Shallow orbits (HP:0000586) | 2.06850421 |
99 | Scanning speech (HP:0002168) | 2.06821057 |
100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05930965 |
101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05930965 |
102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05930965 |
103 | Wormian bones (HP:0002645) | 2.05859805 |
104 | Petechiae (HP:0000967) | 2.03850695 |
105 | Asymmetry of the thorax (HP:0001555) | 2.01350820 |
106 | Neonatal death (HP:0003811) | 2.01168062 |
107 | Abnormal platelet function (HP:0011869) | 2.01112415 |
108 | Impaired platelet aggregation (HP:0003540) | 2.01112415 |
109 | Cellulitis (HP:0100658) | 2.00864113 |
110 | Disproportionate tall stature (HP:0001519) | 2.00615059 |
111 | Hyperammonemia (HP:0001987) | 2.00375849 |
112 | Blue sclerae (HP:0000592) | 2.00231978 |
113 | Progressive muscle weakness (HP:0003323) | 1.98584771 |
114 | Orchitis (HP:0100796) | 1.97359447 |
115 | Recurrent fungal infections (HP:0002841) | 1.97208249 |
116 | Abnormality of reticulocytes (HP:0004312) | 1.95288257 |
117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94013322 |
118 | Obstructive lung disease (HP:0006536) | 1.94013322 |
119 | Hyperglycinemia (HP:0002154) | 1.93817159 |
120 | Abnormality of the thoracic spine (HP:0100711) | 1.92984960 |
121 | Loss of speech (HP:0002371) | 1.92607581 |
122 | Pulmonary infiltrates (HP:0002113) | 1.92574017 |
123 | Biconcave vertebral bodies (HP:0004586) | 1.92210496 |
124 | Ulnar bowing (HP:0003031) | 1.92043111 |
125 | Abnormal gallbladder morphology (HP:0012437) | 1.91622908 |
126 | Entropion (HP:0000621) | 1.91513672 |
127 | Pathologic fracture (HP:0002756) | 1.91015717 |
128 | Cerebral inclusion bodies (HP:0100314) | 1.90831139 |
129 | Spondylolisthesis (HP:0003302) | 1.90731993 |
130 | Poikilocytosis (HP:0004447) | 1.90372022 |
131 | Thrombocytosis (HP:0001894) | 1.90215089 |
132 | Hypoalphalipoproteinemia (HP:0003233) | 1.89977313 |
133 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89576351 |
134 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.89350898 |
135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88720890 |
136 | Abnormality of glycine metabolism (HP:0010895) | 1.88720890 |
137 | Mitral stenosis (HP:0001718) | 1.88101010 |
138 | Bone pain (HP:0002653) | 1.87876072 |
139 | Vascular tortuosity (HP:0004948) | 1.86943882 |
140 | Glomerulosclerosis (HP:0000096) | 1.86895580 |
141 | Coxa vara (HP:0002812) | 1.86230678 |
142 | Prolonged neonatal jaundice (HP:0006579) | 1.85950546 |
143 | Abnormal ossification of hand bones (HP:0005921) | 1.85734663 |
144 | Pterygium (HP:0001059) | 1.85218633 |
145 | Short nail (HP:0001799) | 1.84147439 |
146 | Spinal muscular atrophy (HP:0007269) | 1.83804007 |
147 | Abnormality of the gallbladder (HP:0005264) | 1.83494762 |
148 | Aneurysm (HP:0002617) | 1.81581631 |
149 | Vasculitis (HP:0002633) | 1.81383970 |
150 | Spinal rigidity (HP:0003306) | 1.81333270 |
151 | Fragile skin (HP:0001030) | 1.80349410 |
152 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.79956857 |
153 | Bladder diverticulum (HP:0000015) | 1.79720725 |
154 | Abnormality of the Achilles tendon (HP:0005109) | 1.79581742 |
155 | Fat malabsorption (HP:0002630) | 1.78713795 |
156 | Nausea (HP:0002018) | 1.78660440 |
157 | Purpura (HP:0000979) | 1.77910990 |
158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77816329 |
159 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.77759149 |
160 | Renal duplication (HP:0000075) | 1.77543813 |
161 | Nonimmune hydrops fetalis (HP:0001790) | 1.77479405 |
162 | Neurofibrillary tangles (HP:0002185) | 1.77017778 |
163 | Leukocytosis (HP:0001974) | 1.76663581 |
164 | Vascular calcification (HP:0004934) | 1.76404679 |
165 | Arterial tortuosity (HP:0005116) | 1.76189643 |
166 | Peripheral demyelination (HP:0011096) | 1.75926393 |
167 | Distal lower limb amyotrophy (HP:0008944) | 1.75828358 |
168 | Ileus (HP:0002595) | 1.74647964 |
169 | Back pain (HP:0003418) | 1.73823762 |
170 | Bronchomalacia (HP:0002780) | 1.73411063 |
171 | Abnormality of dentin (HP:0010299) | 1.72390195 |
172 | Long palpebral fissure (HP:0000637) | 1.72291065 |
173 | Stridor (HP:0010307) | 1.70496181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 5.02233684 |
2 | PIM2 | 4.80694328 |
3 | RIPK1 | 4.22920286 |
4 | MAP3K14 | 4.13540622 |
5 | ICK | 3.30199522 |
6 | TBK1 | 3.11353010 |
7 | MAP2K2 | 3.03103869 |
8 | ERN1 | 2.71904734 |
9 | LMTK2 | 2.59884797 |
10 | SMG1 | 2.54617954 |
11 | IKBKB | 2.50431302 |
12 | EEF2K | 2.43479590 |
13 | MAP4K1 | 2.40834226 |
14 | EIF2AK1 | 2.37341703 |
15 | DYRK3 | 2.23916337 |
16 | CDK12 | 2.22497837 |
17 | AKT3 | 2.13791789 |
18 | PDGFRA | 1.96422420 |
19 | NME2 | 1.88250773 |
20 | MAPKAPK3 | 1.85112901 |
21 | PRKD3 | 1.80302497 |
22 | MAP3K11 | 1.80092097 |
23 | CAMKK2 | 1.79619918 |
24 | TGFBR2 | 1.77927943 |
25 | MAP3K3 | 1.72222686 |
26 | MAPK7 | 1.68945262 |
27 | NTRK1 | 1.68806780 |
28 | IKBKE | 1.65652890 |
29 | MET | 1.64310355 |
30 | IRAK3 | 1.62141507 |
31 | CAMK1D | 1.58461732 |
32 | MAPK4 | 1.55703804 |
33 | ABL2 | 1.53061036 |
34 | STK10 | 1.40446012 |
35 | MAP2K3 | 1.36894933 |
36 | RIPK4 | 1.35689021 |
37 | RAF1 | 1.34446781 |
38 | ERBB4 | 1.32933602 |
39 | LATS2 | 1.26272773 |
40 | WNK4 | 1.24908703 |
41 | PDK2 | 1.24256045 |
42 | MAPK15 | 1.22382216 |
43 | MOS | 1.20010010 |
44 | PAK2 | 1.17015351 |
45 | DYRK1B | 1.16946970 |
46 | CHUK | 1.16728614 |
47 | PRKD2 | 1.16039579 |
48 | BLK | 1.15941438 |
49 | RPS6KA6 | 1.15498622 |
50 | TRIB3 | 1.15162127 |
51 | TTN | 1.12163788 |
52 | BMX | 1.12025497 |
53 | PBK | 1.10173223 |
54 | RPS6KC1 | 1.10105008 |
55 | RPS6KL1 | 1.10105008 |
56 | PIM1 | 1.10029670 |
57 | SCYL2 | 1.09472214 |
58 | TAOK2 | 1.06393437 |
59 | GSK3A | 1.05480644 |
60 | PRPF4B | 1.00854292 |
61 | HCK | 0.93288751 |
62 | MST1R | 0.90489695 |
63 | RPS6KA2 | 0.89560970 |
64 | TESK1 | 0.89417306 |
65 | RPS6KB2 | 0.89321970 |
66 | PDPK1 | 0.89278436 |
67 | IRAK4 | 0.87667049 |
68 | STK38 | 0.87456846 |
69 | DDR2 | 0.87241646 |
70 | EPHA2 | 0.84639175 |
71 | EIF2AK2 | 0.84289213 |
72 | DAPK3 | 0.83614735 |
73 | CDK7 | 0.78582675 |
74 | FGFR4 | 0.77291507 |
75 | MAP3K2 | 0.76535863 |
76 | DAPK2 | 0.76527590 |
77 | ABL1 | 0.75854818 |
78 | KIT | 0.75642739 |
79 | RPS6KA1 | 0.75369452 |
80 | NEK9 | 0.72487208 |
81 | TYK2 | 0.72038820 |
82 | TAOK1 | 0.71786837 |
83 | LATS1 | 0.70823298 |
84 | CAMKK1 | 0.70715673 |
85 | LRRK2 | 0.70063606 |
86 | PAK4 | 0.69396474 |
87 | CAMK1G | 0.65955064 |
88 | FLT3 | 0.65780860 |
89 | CSF1R | 0.64773382 |
90 | GRK7 | 0.63044943 |
91 | ERBB2 | 0.61242214 |
92 | SYK | 0.61173363 |
93 | SIK3 | 0.61015060 |
94 | EPHB1 | 0.60692408 |
95 | TIE1 | 0.60295936 |
96 | MAPKAPK2 | 0.59460752 |
97 | ZAP70 | 0.59064299 |
98 | CSK | 0.57678453 |
99 | MAP3K1 | 0.57140945 |
100 | KSR2 | 0.56818790 |
101 | TYRO3 | 0.53841477 |
102 | FGR | 0.53100291 |
103 | MARK2 | 0.52977864 |
104 | WNK1 | 0.52216147 |
105 | PDGFRB | 0.51843558 |
106 | PTK6 | 0.51709352 |
107 | CDC42BPA | 0.51668248 |
108 | PRKG2 | 0.51432445 |
109 | HIPK2 | 0.51245009 |
110 | CDK6 | 0.51174952 |
111 | JAK3 | 0.50547032 |
112 | JAK2 | 0.49650788 |
113 | PIK3CG | 0.49442757 |
114 | EGFR | 0.48495237 |
115 | LCK | 0.47752917 |
116 | AKT2 | 0.47267302 |
117 | LIMK1 | 0.46324873 |
118 | TXK | 0.46078923 |
119 | MAP3K8 | 0.45470983 |
120 | FGFR3 | 0.45384927 |
121 | ARAF | 0.45195708 |
122 | PKN2 | 0.44199187 |
123 | MAP3K12 | 0.43060446 |
124 | FER | 0.42203166 |
125 | MAP3K5 | 0.41838540 |
126 | JAK1 | 0.40687731 |
127 | CSNK1A1L | 0.39172425 |
128 | MYLK | 0.37496546 |
129 | MAPK11 | 0.37153553 |
130 | SIK1 | 0.36774601 |
131 | STK39 | 0.36268661 |
132 | BRAF | 0.36151719 |
133 | RPS6KA4 | 0.33524761 |
134 | FGFR1 | 0.33506399 |
135 | TESK2 | 0.33425666 |
136 | BTK | 0.33312619 |
137 | INSR | 0.33026363 |
138 | MAP2K1 | 0.32935329 |
139 | MTOR | 0.32788871 |
140 | MAPK3 | 0.32603336 |
141 | BRSK1 | 0.32297088 |
142 | LYN | 0.30777685 |
143 | CDK9 | 0.28668014 |
144 | PRKAA2 | 0.28588716 |
145 | ILK | 0.27968092 |
146 | PTK2 | 0.27641608 |
147 | CDK8 | 0.27509409 |
148 | PRKCI | 0.26246741 |
149 | PRKAA1 | 0.26135678 |
150 | EPHB2 | 0.26113343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72026142 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.25253373 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.13119531 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73316977 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48479491 |
6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.41898777 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34651640 |
8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34058470 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24673716 |
10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.23597655 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11455769 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09462788 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03327059 |
14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.93976267 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86489952 |
16 | Pertussis_Homo sapiens_hsa05133 | 1.81741711 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80030140 |
18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.78021305 |
19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76848085 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75740139 |
21 | Legionellosis_Homo sapiens_hsa05134 | 1.73834457 |
22 | Malaria_Homo sapiens_hsa05144 | 1.69647041 |
23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63312082 |
24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61333384 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.58298823 |
26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.57214144 |
27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.56720053 |
28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46324721 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.43837977 |
30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40803995 |
31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.40283234 |
32 | Phagosome_Homo sapiens_hsa04145 | 1.34688916 |
33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34601645 |
34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32778316 |
35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30497626 |
36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.29929073 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.28788502 |
38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27675786 |
39 | Salmonella infection_Homo sapiens_hsa05132 | 1.23405292 |
40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22819409 |
41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17832444 |
42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.17388572 |
43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15386593 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14018037 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13378078 |
46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11531934 |
47 | Bladder cancer_Homo sapiens_hsa05219 | 1.11249763 |
48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09981824 |
49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09567143 |
50 | Shigellosis_Homo sapiens_hsa05131 | 1.09035006 |
51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05984563 |
52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04640604 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04162696 |
54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03657190 |
55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03592705 |
56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01405483 |
57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00971315 |
58 | Focal adhesion_Homo sapiens_hsa04510 | 0.99016670 |
59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98818878 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98594957 |
61 | Prostate cancer_Homo sapiens_hsa05215 | 0.95278235 |
62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94627278 |
63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94377055 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92677221 |
65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91446343 |
66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91051557 |
67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90884807 |
68 | Bile secretion_Homo sapiens_hsa04976 | 0.90765332 |
69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90347801 |
70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89944570 |
71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88974065 |
72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88420141 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88238474 |
74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88143446 |
75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88116323 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87251587 |
77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85682340 |
78 | ABC transporters_Homo sapiens_hsa02010 | 0.84633927 |
79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84204515 |
80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83691703 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83326170 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.79957643 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.79283200 |
84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79147462 |
85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78386753 |
86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77577612 |
87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75632869 |
88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75289449 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.74362982 |
90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73637094 |
91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73310346 |
92 | Influenza A_Homo sapiens_hsa05164 | 0.71379892 |
93 | Glioma_Homo sapiens_hsa05214 | 0.71368998 |
94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71222986 |
95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70901443 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70187152 |
97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70107165 |
98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69623809 |
99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69489672 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.69285665 |
101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68774268 |
102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68670405 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68623012 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68111672 |
105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67844907 |
106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67572779 |
107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65477816 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.63261125 |
109 | Lysine degradation_Homo sapiens_hsa00310 | 0.61746384 |
110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60527814 |
111 | Peroxisome_Homo sapiens_hsa04146 | 0.60194626 |
112 | Adherens junction_Homo sapiens_hsa04520 | 0.58663663 |
113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57866553 |
114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57747661 |
115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57713240 |
116 | Hepatitis C_Homo sapiens_hsa05160 | 0.57454036 |
117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56947112 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56234519 |
119 | Measles_Homo sapiens_hsa05162 | 0.56050877 |
120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55181465 |
121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55024186 |
122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54140350 |
123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52428958 |
124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52374588 |
125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51155639 |
126 | Melanoma_Homo sapiens_hsa05218 | 0.50997917 |
127 | Tight junction_Homo sapiens_hsa04530 | 0.49948995 |
128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47689428 |
129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47346787 |
130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46250344 |
131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45670625 |
132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44616656 |
133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44393558 |
134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44352870 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43670792 |
136 | Endocytosis_Homo sapiens_hsa04144 | 0.41826437 |
137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41500228 |
138 | Asthma_Homo sapiens_hsa05310 | 0.41458395 |
139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41045345 |
140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40882305 |
141 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40686048 |
142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40230209 |
143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39685795 |
144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38618850 |
145 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38499814 |
146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37626636 |
147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36792493 |
148 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36506787 |
149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36444616 |
150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36280085 |
151 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34902192 |
152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34579696 |
153 | Mineral absorption_Homo sapiens_hsa04978 | 0.33478530 |
154 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33400471 |
155 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33060177 |
156 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30565218 |
157 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30223112 |